Novo Nordisk shares rise as Biden proposes obesity care coverage
Shares of Novo Nordisk increased by 1.3% after U.S. President Joe Biden proposed expanding coverage of anti-obesity drugs for Medicare and Medicaid recipients. Novo Nordisk welcomed the move, stating it would benefit patients and could take effect in 2026.